KELI Therapeutics is a biotechnology company on a mission to develop treatments that prioritize the needs and well-being of patients. We are helping to deliver innovative treatment solutions for highly unmet medical needs.

We develop and manufacture cellular and extracellular vesicle therapeutic prototypes and products following Good Manufacturing Practice requirements for  impaired immunology and inflammatory conditions

The original EU-India Innocenter project received funding from the European Union's Horizon 2020
Coordination and Support Action Program under Grant Agreement No. 101004815 and was created with love by: